Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Sep;85(6):808–815. doi: 10.1054/bjoc.2001.1955

Progress in the management and outcome of small-cell lung cancer in a French region from 1981 to 1994

M P Lebitasy 1, G Hédelin 2, A Purohit 1, L Moreau 1, F Klinzig 1, E Quoix 1
PMCID: PMC2375085  PMID: 11556829

Abstract

Recent analyses of series of small-cell lung cancer (SCLC) patients included in clinical trials have shown improved survival over time, but it has been impossible to determine whether this was due to selection biases, stage migration, or true therapeutic improvement. To determine if there has been a true improvement of survival over time, we reviewed the medical records of all consecutive patients diagnosed with SCLC between 1981 and 1994 in the Bas-Rhin in France. Among the 787 patients (median age 63), there was no significant period effect for sex, age, or stage. Staging work-ups became increasingly thorough (significant period effect). The mean number of investigations and of tumour sites detected correlated significantly. The chemotherapy rate increased (from 76.4% in 1981–1983 to 91.7% in 1993–1994, P = 10−5) and mediastinal irradiation decreased (to roughly 25% of patients after 1983). Median survival time increased for the overall population from 6.6 months in 1981–1983 to 11.3 months in 1993–1994 (P = 10−5), for patients with limited disease (LD) from 9.2 (P = 0.002) months to 14.0 months, and for those with extensive (ED) disease from 3.5 months to 9.6 months (P = 10−5). Significant independent prognostic factors were disease extent, clinical trial participation, period, type of chemotherapy, and mediastinal irradiation in LD. Survival time has truly improved as ‘state of the art' management of SCLC has changed. © 2001 Cancer Research Campaignhttp://www.bjcancer.com

Keywords: small-cell lung cancer, survival, management, chemotherapy, prognosis

Full Text

The Full Text of this article is available as a PDF (94.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aisner J., Alberto P., Bitran J., Comis R., Daniels J., Hansen H., Ikegami H., Smyth J. Role of chemotherapy in small cell lung cancer: a consensus report of the International Association for the Study of Lung Cancer workshop. Cancer Treat Rep. 1983 Jan;67(1):37–43. [PubMed] [Google Scholar]
  2. Albain K. S., Crowley J. J., LeBlanc M., Livingston R. B. Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base. J Clin Oncol. 1990 Sep;8(9):1563–1574. doi: 10.1200/JCO.1990.8.9.1563. [DOI] [PubMed] [Google Scholar]
  3. Antman K., Amato D., Wood W., Carson J., Suit H., Proppe K., Carey R., Greenberger J., Wilson R., Frei E., 3rd Selection bias in clinical trials. J Clin Oncol. 1985 Aug;3(8):1142–1147. doi: 10.1200/JCO.1985.3.8.1142. [DOI] [PubMed] [Google Scholar]
  4. Black R. J., Bray F., Ferlay J., Parkin D. M. Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. Eur J Cancer. 1997 Jun;33(7):1075–1107. doi: 10.1016/s0959-8049(96)00492-3. [DOI] [PubMed] [Google Scholar]
  5. Chute J. P., Chen T., Feigal E., Simon R., Johnson B. E. Twenty years of phase III trials for patients with extensive-stage small-cell lung cancer: perceptible progress. J Clin Oncol. 1999 Jun;17(6):1794–1801. doi: 10.1200/JCO.1999.17.6.1794. [DOI] [PubMed] [Google Scholar]
  6. Chute J. P., Venzon D. J., Hankins L., Okunieff P., Frame J. N., Ihde D. C., Johnson B. E. Outcome of patients with small-cell lung cancer during 20 years of clinical research at the US National Cancer Institute. Mayo Clin Proc. 1997 Oct;72(10):901–912. doi: 10.1016/S0025-6196(11)63359-4. [DOI] [PubMed] [Google Scholar]
  7. Dajczman E., Fu L. Y., Small D., Wolkove N., Kreisman H. Treatment of small cell lung carcinoma in the elderly. Cancer. 1996 May 15;77(10):2032–2038. doi: 10.1002/(SICI)1097-0142(19960515)77:10<2032::AID-CNCR10>3.0.CO;2-W. [DOI] [PubMed] [Google Scholar]
  8. Davis S., Wright P. W., Schulman S. F., Scholes D., Thorning D., Hammar S. Long-term survival in small-cell carcinoma of the lung: a population experience. J Clin Oncol. 1985 Jan;3(1):80–91. doi: 10.1200/JCO.1985.3.1.80. [DOI] [PubMed] [Google Scholar]
  9. Dearing M. P., Steinberg S. M., Phelps R., Anderson M. J., Mulshine J. L., Ihde D. C., Johnson B. E. Outcome of patients with small-cell lung cancer: effect of changes in staging procedures and imaging technology on prognostic factors over 14 years. J Clin Oncol. 1990 Jun;8(6):1042–1049. doi: 10.1200/JCO.1990.8.6.1042. [DOI] [PubMed] [Google Scholar]
  10. Engeland A., Bjørge T., Haldorsen T., Tretli S. Prognosis of patients with lung cancer diagnosed in Norway, 1954-93. Cancer Causes Control. 1998 Jan;9(1):57–65. doi: 10.1023/a:1008849320175. [DOI] [PubMed] [Google Scholar]
  11. Evans W. K., Shepherd F. A., Feld R., Osoba D., Dang P., Deboer G. VP-16 and cisplatin as first-line therapy for small-cell lung cancer. J Clin Oncol. 1985 Nov;3(11):1471–1477. doi: 10.1200/JCO.1985.3.11.1471. [DOI] [PubMed] [Google Scholar]
  12. Feinstein A. R., Sosin D. M., Wells C. K. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med. 1985 Jun 20;312(25):1604–1608. doi: 10.1056/NEJM198506203122504. [DOI] [PubMed] [Google Scholar]
  13. Fox W., Scadding J. G. Medical Research Council comparative trial of surgery and radiotherapy for primary treatment of small-celled or oat-celled carcinoma of bronchus. Ten-year follow-up. Lancet. 1973 Jul 14;2(7820):63–65. doi: 10.1016/s0140-6736(73)93260-1. [DOI] [PubMed] [Google Scholar]
  14. Fry W. A., Phillips J. L., Menck H. R. Ten-year survey of lung cancer treatment and survival in hospitals in the United States: a national cancer data base report. Cancer. 1999 Nov 1;86(9):1867–1876. doi: 10.1002/(sici)1097-0142(19991101)86:9<1867::aid-cncr31>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  15. Fukuoka M., Furuse K., Saijo N., Nishiwaki Y., Ikegami H., Tamura T., Shimoyama M., Suemasu K. Randomized trial of cyclophosphamide, doxorubicin, and vincristine versus cisplatin and etoposide versus alternation of these regimens in small-cell lung cancer. J Natl Cancer Inst. 1991 Jun 19;83(12):855–861. doi: 10.1093/jnci/83.12.855. [DOI] [PubMed] [Google Scholar]
  16. Giaccone G., Donadio M., Bonardi G., Testore F., Calciati A. Teniposide in the treatment of small-cell lung cancer: the influence of prior chemotherapy. J Clin Oncol. 1988 Aug;6(8):1264–1270. doi: 10.1200/JCO.1988.6.8.1264. [DOI] [PubMed] [Google Scholar]
  17. Green R. A., Humphrey E., Close H., Patno M. E. Alkylating agents in bronchogenic carcinoma. Am J Med. 1969 Apr;46(4):516–525. doi: 10.1016/0002-9343(69)90071-0. [DOI] [PubMed] [Google Scholar]
  18. Griffin C. A., Lu C., Fishman E. K., Khouri N., Markman M., Siegelman S. S., Abeloff M. D. The role of computed tomography of the chest in the management of small-cell lung cancer. J Clin Oncol. 1984 Dec;2(12):1359–1365. doi: 10.1200/JCO.1984.2.12.1359. [DOI] [PubMed] [Google Scholar]
  19. Humblet Y., Symann M., Bosly A., Delaunois L., Francis C., Machiels J., Beauduin M., Doyen C., Weynants P., Longueville J. Late intensification chemotherapy with autologous bone marrow transplantation in selected small-cell carcinoma of the lung: a randomized study. J Clin Oncol. 1987 Dec;5(12):1864–1873. doi: 10.1200/JCO.1987.5.12.1864. [DOI] [PubMed] [Google Scholar]
  20. Janssen-Heijnen M. L., Gatta G., Forman D., Capocaccia R., Coebergh J. W. Variation in survival of patients with lung cancer in Europe, 1985-1989. EUROCARE Working Group. Eur J Cancer. 1998 Dec;34(14 Spec No):2191–2196. doi: 10.1016/s0959-8049(98)00312-8. [DOI] [PubMed] [Google Scholar]
  21. Janssen-Heijnen M. L., Nab H. W., van Reek J., van der Heijden L. H., Schipper R., Coebergh J. W. Striking changes in smoking behaviour and lung cancer incidence by histological type in south-east Netherlands, 1960-1991. Eur J Cancer. 1995 Jun;31A(6):949–952. doi: 10.1016/0959-8049(94)00519-2. [DOI] [PubMed] [Google Scholar]
  22. Janssen-Heijnen M. L., Schipper R. M., Klinkhamer P. J., Crommelin M. A., Coebergh J. W. Improvement and plateau in survival of small-cell lung cancer since 1975: a population-based study. Ann Oncol. 1998 May;9(5):543–547. doi: 10.1023/a:1008257129062. [DOI] [PubMed] [Google Scholar]
  23. Johnson B. E., Steinberg S. M., Phelps R., Edison M., Veach S. R., Ihde D. C. Female patients with small cell lung cancer live longer than male patients. Am J Med. 1988 Aug;85(2):194–196. doi: 10.1016/s0002-9343(88)80341-3. [DOI] [PubMed] [Google Scholar]
  24. Lassen U., Osterlind K., Hansen M., Dombernowsky P., Bergman B., Hansen H. H. Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years--an analysis of 1,714 consecutive patients. J Clin Oncol. 1995 May;13(5):1215–1220. doi: 10.1200/JCO.1995.13.5.1215. [DOI] [PubMed] [Google Scholar]
  25. Lebeau B., Chastang C., Schuller M. P., Thiberville L., Vaylet F., Derenne J. P., Caillaud D., Muir J. F., Coëtmeur D., Lemarié E. Chimiothérapie des cancers bronchiques à petites cellules. Importance pronostique d'une réponse complète (1,280 patients). Groupe Petites Cellules. Presse Med. 1995 Jan 28;24(4):217–221. [PubMed] [Google Scholar]
  26. Livingston R. B., Moore T. N., Heilbrun L., Bottomley R., Lehane D., Rivkin S. E., Thigpen T. Small-cell carcinoma of the lung: combined chemotherapy and radiation: a Southwest Oncology Group study. Ann Intern Med. 1978 Feb;88(2):194–199. doi: 10.7326/0003-4819-88-2-194. [DOI] [PubMed] [Google Scholar]
  27. Maestu I., Pastor M., Gómez-Codina J., Aparicio J., Oltra A., Herranz C., Montalar J., Munárriz B., Reynés G. Pretreatment prognostic factors for survival in small-cell lung cancer: a new prognostic index and validation of three known prognostic indices on 341 patients. Ann Oncol. 1997 Jun;8(6):547–553. doi: 10.1023/a:1008212826956. [DOI] [PubMed] [Google Scholar]
  28. Maurer L. H., Pajak T. F. Prognostic factors in small cell carcinoma of the lung: a cancer and leukemia group B study. Cancer Treat Rep. 1981 Sep-Oct;65(9-10):767–774. [PubMed] [Google Scholar]
  29. Osterlind K., Andersen P. K. Prognostic factors in small cell lung cancer: multivariate model based on 778 patients treated with chemotherapy with or without irradiation. Cancer Res. 1986 Aug;46(8):4189–4194. [PubMed] [Google Scholar]
  30. Parkin D. M., Pisani P., Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer. 1993 Jun 19;54(4):594–606. doi: 10.1002/ijc.2910540413. [DOI] [PubMed] [Google Scholar]
  31. Perry M. C., Eaton W. L., Propert K. J., Ware J. H., Zimmer B., Chahinian A. P., Skarin A., Carey R. W., Kreisman H., Faulkner C. Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung. N Engl J Med. 1987 Apr 9;316(15):912–918. doi: 10.1056/NEJM198704093161504. [DOI] [PubMed] [Google Scholar]
  32. Pignon J. P., Arriagada R., Ihde D. C., Johnson D. H., Perry M. C., Souhami R. L., Brodin O., Joss R. A., Kies M. S., Lebeau B. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med. 1992 Dec 3;327(23):1618–1624. doi: 10.1056/NEJM199212033272302. [DOI] [PubMed] [Google Scholar]
  33. Pujol J. L., Carestia L., Daurès J. P. Is there a case for cisplatin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkylating agent. Br J Cancer. 2000 Jul;83(1):8–15. doi: 10.1054/bjoc.2000.1164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Quoix E., Finkelstein H., Wolkove N., Kreisman H. Treatment of small-cell lung cancer on protocol: potential bias of results. J Clin Oncol. 1986 Sep;4(9):1314–1320. doi: 10.1200/JCO.1986.4.9.1314. [DOI] [PubMed] [Google Scholar]
  35. Quoix E., Purohit A., Faller-Beau M., Moreau L., Oster J. P., Pauli G. Comparative prognostic value of lactate dehydrogenase and neuron-specific enolase in small-cell lung cancer patients treated with platinum-based chemotherapy. Lung Cancer. 2000 Nov;30(2):127–134. doi: 10.1016/s0169-5002(00)00131-8. [DOI] [PubMed] [Google Scholar]
  36. Rawson N. S., Peto J. An overview of prognostic factors in small cell lung cancer. A report from the Subcommittee for the Management of Lung Cancer of the United Kingdom Coordinating Committee on Cancer Research. Br J Cancer. 1990 Apr;61(4):597–604. doi: 10.1038/bjc.1990.133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Roth B. J., Johnson D. H., Einhorn L. H., Schacter L. P., Cherng N. C., Cohen H. J., Crawford J., Randolph J. A., Goodlow J. L., Broun G. O. Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group. J Clin Oncol. 1992 Feb;10(2):282–291. doi: 10.1200/JCO.1992.10.2.282. [DOI] [PubMed] [Google Scholar]
  38. Sagman U., Maki E., Evans W. K., Warr D., Shepherd F. A., Sculier J. P., Haddad R., Payne D., Pringle J. F., Yeoh J. L. Small-cell carcinoma of the lung: derivation of a prognostic staging system. J Clin Oncol. 1991 Sep;9(9):1639–1649. doi: 10.1200/JCO.1991.9.9.1639. [DOI] [PubMed] [Google Scholar]
  39. Silverberg E., Lubera J. A. Cancer statistics, 1988. CA Cancer J Clin. 1988 Jan-Feb;38(1):5–22. doi: 10.3322/canjclin.38.1.5. [DOI] [PubMed] [Google Scholar]
  40. Souhami R. L., Geddes D. M., Spiro S. G., Harper P. G., Tobias J. S., Mantell B. S., Fearon F., Bradbury I. Radiotherapy in small cell cancer of the lung treated with combination chemotherapy: a controlled trial. Br Med J (Clin Res Ed) 1984 Jun 2;288(6431):1643–1646. doi: 10.1136/bmj.288.6431.1643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Spiegelman D., Maurer L. H., Ware J. H., Perry M. C., Chahinian A. P., Comis R., Eaton W., Zimmer B., Green M. Prognostic factors in small-cell carcinoma of the lung: an analysis of 1,521 patients. J Clin Oncol. 1989 Mar;7(3):344–354. doi: 10.1200/JCO.1989.7.3.344. [DOI] [PubMed] [Google Scholar]
  42. Trimble E. L., Carter C. L., Cain D., Freidlin B., Ungerleider R. S., Friedman M. A. Representation of older patients in cancer treatment trials. Cancer. 1994 Oct 1;74(7 Suppl):2208–2214. doi: 10.1002/1097-0142(19941001)74:7+<2208::aid-cncr2820741737>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  43. Warde P., Payne D. Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J Clin Oncol. 1992 Jun;10(6):890–895. doi: 10.1200/JCO.1992.10.6.890. [DOI] [PubMed] [Google Scholar]
  44. Wolf M., Holle R., Hans K., Drings P., Havemann K. Analysis of prognostic factors in 766 patients with small cell lung cancer (SCLC): the role of sex as a predictor for survival. Br J Cancer. 1991 Jun;63(6):986–992. doi: 10.1038/bjc.1991.215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Zelen M. Keynote address on biostatistics and data retrieval. Cancer Chemother Rep 3. 1973 Mar;4(2):31–42. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES